The pan-HDACi rodempsin was reported to increase the expression of chemokines CCL5 and CXCL9 and 10 by tumor and stromal cells, increasing tumor infiltration with T cells and thereby improving the antitumor immune response [216]. Here, CXCL9 is linked to neoplasm.